City

Aarhus (1)

Lyon (1)

Taipei (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

n/a (2)

Sponsor

Centre Leon Berard (1)

Karen-Lise Garm Spindler (1)

Taipei Medical University WanFang Hospital (1)

Collaborator

Intervention

cicaplast balm b5 (1)

cryotherapy with liquid nitrogen (1)

dexeryl (1)

plasma circulating dna analysis (1)

timolol maleate 0.5% ophthalmic solution (1)

Study Documents

Intervention Type

other (2)

drug (1)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

epidermal growth factor receptor inhibitor

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Paronychia, Epidermal Growth Factor Receptor Inhibitor Trial in Taipei (Timolol maleate 0.5% ophthalmic solution, Cryotherapy

Recruiting

Paronychia
Epidermal Growth Factor Receptor Inhibitor

Timolol maleate 0.5% ophthalmic solution
Cryotherapy with liquid nitrogen

Taipei, Taiwan

Taipei Municipal Wan-Fang Hospital

Jun 7, 2022

OPTImal PALliative Anti-epidermal Growth Factor Receptor

Active, not recruiting

Colorectal Cancer Metastatic
+5 more

Plasma circulating DNA analysis

Aarhus, Denmark

Aarhus University Hospital

Feb 24, 2022

Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Non Small Cell Lung Cancer Trial in Lyon (Cicaplast Balm B5, Dexeryl)

Completed

Head and Neck Squamous Cell Carcinoma
+3 more

Cicaplast Balm B5
Dexeryl

Lyon, Rhône, France

Centre Léon Bérard

Jul 8, 2021